Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pircher

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Plos One|May 29, 2015
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Wolfgang Hilbe, Georg Pall, Florian Kocher, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2015
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registryFlorian Kocher, Wolfgang Hilbe, Andreas Seeber, et al.
European Urology Oncology|November 27, 2020
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?Isabel Heidegger, Andrea Necchi, Andreas Pircher, et al.
Oncoimmunology|December 21, 2023
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLCStefan Koeck, Arno Amann, Johan Kern, et al.
Bone Reports|April 9, 2024
Intravenous iron-induced hypophosphatemia and kidney stone diseaseMarlene Panzer, Eva Meindl, Benedikt Schaefer, et al.
American Journal of Hematology|March 7, 2023
Tissue iron distribution in patients with anemia of inflammation: Results of a pilot studyLukas Lanser, Michaela Plaikner, Andrea Schroll, et al.
Oncogene|November 28, 2023
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Florian Handle, Silvia Schanung, et al.
Nucleic Acids Research|October 26, 2018
EndoDB: a database of endothelial cell transcriptomics dataShawez Khan, Federico Taverna, Katerina Rohlenova, et al.
European Urology Oncology|June 9, 2024
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome SignatureIsabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
Nature Medicine|July 11, 2018
Phenotype molding of stromal cells in the lung tumor microenvironmentDiether Lambrechts, Els Wauters, Bram Boeckx, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Plos One|May 29, 2015
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Wolfgang Hilbe, Georg Pall, Florian Kocher, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2015
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registryFlorian Kocher, Wolfgang Hilbe, Andreas Seeber, et al.
European Urology Oncology|November 27, 2020
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?Isabel Heidegger, Andrea Necchi, Andreas Pircher, et al.
Oncoimmunology|December 21, 2023
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLCStefan Koeck, Arno Amann, Johan Kern, et al.
Bone Reports|April 9, 2024
Intravenous iron-induced hypophosphatemia and kidney stone diseaseMarlene Panzer, Eva Meindl, Benedikt Schaefer, et al.
American Journal of Hematology|March 7, 2023
Tissue iron distribution in patients with anemia of inflammation: Results of a pilot studyLukas Lanser, Michaela Plaikner, Andrea Schroll, et al.
Oncogene|November 28, 2023
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Florian Handle, Silvia Schanung, et al.
Nucleic Acids Research|October 26, 2018
EndoDB: a database of endothelial cell transcriptomics dataShawez Khan, Federico Taverna, Katerina Rohlenova, et al.
European Urology Oncology|June 9, 2024
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome SignatureIsabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
Nature Medicine|July 11, 2018
Phenotype molding of stromal cells in the lung tumor microenvironmentDiether Lambrechts, Els Wauters, Bram Boeckx, et al.
Pageof 10